Results 81 to 90 of about 15,050 (215)
Twelve‐Month Real‐World Outcomes of Faricimab for Treatment‐Naive Neovascular AMD in Australia
ABSTRACT Background To provide insights into the effectiveness and safety of faricimab for treatment‐naïve eyes with neovascular age‐related macular degeneration (nAMD). Methods A retrospective cohort study using a prospectively‐designed registry. Treatment‐naïve eyes with nAMD in Australia starting treatment with faricimab between Jan 2023–Sep 2024 ...
Mark Gillies +8 more
wiley +1 more source
DisclaimerThis publication and the expert roundtable meeting on which the article is based were sponsored by Bayer plc. Prescribing information for Eylea® (aflibercept solution for injection) can be found at the end of the article.AbstractThis report by ...
R. Gale +10 more
semanticscholar +1 more source
Abstract For over four decades we have collaborated as a team of anthropologists and Indigenous Elders of the Yanyuwa language group. The Yanyuwa are the Indigenous owners of lands and waters in Australia's Gulf of Carpentaria. While medicalized healthcare has not been our specific research focus, wellness and ill health have been recurring themes ...
Amanda Kearney +3 more
wiley +1 more source
ObjectivesTo characterize the pattern of approved anti-vascular endothelial growth factor (VEGF) treatments among patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) in the United Arab Emirates (UAE ...
Igor Kozak +9 more
doaj +1 more source
Communicating with patients with nAMD and their families during the COVID-19 pandemic
Dear Editor, In discussion with colleagues around the world, we have identified a critical gap of guidance for clinicians to communicate with patients and their families about how to minimize exposure whilst undertaking crucial eye care services during ...
J. Korobelnik +14 more
semanticscholar +1 more source
Abstract Molecular simulation techniques have become an invaluable tool for elucidating the fundamental principles of life at the molecular level. After nearly five decades of development, biomolecular simulations have evolved to enable the quantitative characterization of complex biomolecular events, such as protein folding, conformational dynamics ...
Wenfei Li, Wei Wang
wiley +1 more source
Background Dysregulation of the complement system is involved in development of age-related macular degeneration (AMD). The complement cascade is regulated by membrane bound complement regulatory proteins (Cregs) on mononuclear leukocytes among others ...
Alexander Kai Thomsen +7 more
doaj +1 more source
Risk of Parkinson’s disease in patients with neovascular age-related macular degeneration
Purpose: To examine the risk of developing Parkinson's Disease (PD) in patients who are newly diagnosed with neovascular age-related macular degeneration (nAMD).
Mahyar Etminan, Ali Samii, Bonnie He
doaj +1 more source
Background To determine the frequency of persistent disease activity following 3 loading doses of anti- vascular endothelial growth factor (VEGF) agents, and the anatomic and demographic predictors of early persistent disease activity among patients with
Colin S. Tan +6 more
semanticscholar +1 more source
Abstract Purpose This systematic review aims to evaluate and synthesize the existing literature on the interventions used for submacular haemorrhage (SMH), highlighting the controversies and differences in clinical practice. Method A systematic review was conducted following the PRISMA guidelines.
Salvador Pastor‐Idoate +6 more
wiley +1 more source

